» Articles » PMID: 38472948

A Case of Castleman's Disease with a Marked Infiltration of IgG4-Positive Cells in the Renal Interstitium

Overview
Specialty Radiology
Date 2024 Mar 13
PMID 38472948
Authors
Affiliations
Soon will be listed here.
Abstract

Multicentric Castleman's disease (MCD) is a benign lymphoproliferative disorder with heterogenous clinical symptoms, and involves systemic organs in addition to lymph nodes. Herein, we present the case of a 55-year-old man with MCD characterized by an extensive infiltration of IgG4+ plasma cells in the kidneys. The patient presented to our hospital with a high fever and diarrhea. On admission, laboratory analysis revealed anemia, renal dysfunction (eGFR 30 mL/min/1.73 m), polyclonal gammopathy (IgG 7130 mg/dL), elevated serum IgG4 level (2130 mg/dL), and increased C-reactive protein (8.0 mg/dL). An enlargement of lymph nodes in the axillary, mediastinal, para-aortic, and inguinal regions was observed on abdominal computed tomography. Axillary lymph node biopsy revealed interfollicular expansion due to dense plasma cell infiltration. Renal biopsy demonstrated significant plasma cell infiltration into the tubulointerstitium. Immunohistochemical analysis showed a 40% IgG4-positive/IgG-positive plasma cell ratio, meeting the diagnostic criteria for an IgG4-related disease. Amyloid A deposition was observed along vessel walls, and immunofluorescence analysis indicated granular positivity of IgG and C3 along the glomerular capillary wall. Elevated levels of interleukin-6 (21 pg/mL) and vascular endothelial growth factor (VEGF; 1210 pg/mL) were noted. Based on these findings, and the histological finding of the lymph node biopsy, idiopathic MCD was diagnosed. Corticosteroid monotherapy was only partially effective. Subsequently, tocilizumab administration was initiated, leading to sustained remission, even after discontinuation of prednisolone. Due to the diverse responses to steroid therapy and the varying prognoses observed in MCD and IgG4-related disease, it is essential to carefully diagnose MCD by thoroughly assessing the organ distribution of the disease, its response to steroid therapy, and any additional pathological findings.

Citing Articles

IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report.

Huang M, Liu J, Li X Open Life Sci. 2024; 19(1):20220921.

PMID: 39071497 PMC: 11282913. DOI: 10.1515/biol-2022-0921.

References
1.
Zen Y, Nakanuma Y . IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010; 34(12):1812-9. DOI: 10.1097/PAS.0b013e3181f7266b. View

2.
Castleman B, IVERSON L, MENENDEZ V . Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956; 9(4):822-30. DOI: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. View

3.
Fajgenbaum D, Uldrick T, Bagg A, Frank D, Wu D, Srkalovic G . International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017; 129(12):1646-1657. PMC: 5364342. DOI: 10.1182/blood-2016-10-746933. View

4.
Sun D, Chen W, Wang L, Wang Z, Liang J, Zhu H . Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases. J Cancer Res Clin Oncol. 2021; 147(7):2107-2115. PMC: 8164599. DOI: 10.1007/s00432-020-03494-2. View

5.
Yuan X, Hu W, Chen F, Huang B, Zhao X . Renal complications of Castleman's disease: report of two cases and analysis of 75 cases. Clin Exp Nephrol. 2011; 15(6):921-6. DOI: 10.1007/s10157-011-0499-9. View